Pavan Kumar Prathipati

621 total citations
19 papers, 460 citations indexed

About

Pavan Kumar Prathipati is a scholar working on Infectious Diseases, Virology and Epidemiology. According to data from OpenAlex, Pavan Kumar Prathipati has authored 19 papers receiving a total of 460 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Infectious Diseases, 13 papers in Virology and 4 papers in Epidemiology. Recurrent topics in Pavan Kumar Prathipati's work include HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Pavan Kumar Prathipati is often cited by papers focused on HIV Research and Treatment (13 papers), HIV/AIDS drug development and treatment (10 papers) and HIV/AIDS Research and Interventions (8 papers). Pavan Kumar Prathipati collaborates with scholars based in United States and China. Pavan Kumar Prathipati's co-authors include Christopher J. Destache, Subhra Mandal, Qingsheng Li, Guobin Kang, You Zhou, Zhe Yuan, Michael Belshan, Renuga Vivekanandan, Mary Jackson and Dunesh Kumari and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Controlled Release and Journal of Medicinal Chemistry.

In The Last Decade

Pavan Kumar Prathipati

19 papers receiving 455 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Pavan Kumar Prathipati United States 13 301 191 110 102 44 19 460
Timothy McCormick United States 10 217 0.7× 138 0.7× 110 1.0× 68 0.7× 43 1.0× 25 483
Guenter Kraus Belgium 9 533 1.8× 483 2.5× 114 1.0× 115 1.1× 38 0.9× 14 718
Inês Bártolo Portugal 16 313 1.0× 338 1.8× 86 0.8× 76 0.7× 20 0.5× 36 573
Yeojin Park United States 13 251 0.8× 64 0.3× 207 1.9× 139 1.4× 29 0.7× 22 551
Jeong-Joong Yoon United States 16 455 1.5× 95 0.5× 434 3.9× 180 1.8× 52 1.2× 22 912
Murty N. Arimilli United States 8 242 0.8× 152 0.8× 147 1.3× 142 1.4× 8 0.2× 9 410
Carrie A. Rutkowski United States 11 295 1.0× 113 0.6× 138 1.3× 196 1.9× 19 0.4× 13 518
Yi-Fei Gong United States 9 598 2.0× 575 3.0× 70 0.6× 138 1.4× 17 0.4× 10 754
Sophie Lachau‐Durand Belgium 10 185 0.6× 59 0.3× 46 0.4× 49 0.5× 55 1.3× 17 405
Katie Amssoms Belgium 12 93 0.3× 79 0.4× 88 0.8× 112 1.1× 78 1.8× 18 424

Countries citing papers authored by Pavan Kumar Prathipati

Since Specialization
Citations

This map shows the geographic impact of Pavan Kumar Prathipati's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pavan Kumar Prathipati with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pavan Kumar Prathipati more than expected).

Fields of papers citing papers by Pavan Kumar Prathipati

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pavan Kumar Prathipati. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pavan Kumar Prathipati. The network helps show where Pavan Kumar Prathipati may publish in the future.

Co-authorship network of co-authors of Pavan Kumar Prathipati

This figure shows the co-authorship network connecting the top 25 collaborators of Pavan Kumar Prathipati. A scholar is included among the top collaborators of Pavan Kumar Prathipati based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pavan Kumar Prathipati. Pavan Kumar Prathipati is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Li, Wei, Pavan Kumar Prathipati, Amit N. Pandya, et al.. (2022). Structural Determinants of Indole-2-carboxamides: Identification of Lead Acetamides with Pan Antimycobacterial Activity. Journal of Medicinal Chemistry. 66(1). 170–187. 10 indexed citations
2.
Li, Yupeng, Jitender Mehla, Pavan Kumar Prathipati, et al.. (2022). Proton transfer activity of the reconstituted Mycobacterium tuberculosis MmpL3 is modulated by substrate mimics and inhibitors. Proceedings of the National Academy of Sciences. 119(30). e2113963119–e2113963119. 17 indexed citations
3.
Mandal, Subhra, et al.. (2022). Targeted Immuno-Antiretroviral to Promote Dual Protection against HIV: A Proof-of-Concept Study. Nanomaterials. 12(11). 1942–1942. 1 indexed citations
4.
5.
Prathipati, Pavan Kumar, et al.. (2021). Formulation and characterization of ternary amorphous solid dispersions of a highly potent anti-tubercular agent and curcumin. Journal of Drug Delivery Science and Technology. 64. 102564–102564. 15 indexed citations
6.
7.
Mandal, Subhra, Pavan Kumar Prathipati, Michael Belshan, & Christopher J. Destache. (2019). A potential long-acting bictegravir loaded nano-drug delivery system for HIV-1 infection: A proof-of-concept study. Antiviral Research. 167. 83–88. 28 indexed citations
8.
Prathipati, Pavan Kumar, Subhra Mandal, & Christopher J. Destache. (2019). A Review of CCR5 Antibodies Against HIV: Current and Future Aspects. Therapeutic Delivery. 10(2). 107–112. 5 indexed citations
9.
Pandya, Amit N., Pavan Kumar Prathipati, Wěi Li, et al.. (2019). Indole-2-Carboxamides Are Active against Mycobacterium abscessus in a Mouse Model of Acute Infection. Antimicrobial Agents and Chemotherapy. 63(3). 31 indexed citations
10.
Mandal, Subhra, Guobin Kang, Pavan Kumar Prathipati, et al.. (2018). Nanoencapsulation introduces long-acting phenomenon to tenofovir alafenamide and emtricitabine drug combination: A comparative pre-exposure prophylaxis efficacy study against HIV-1 vaginal transmission. Journal of Controlled Release. 294. 216–225. 37 indexed citations
11.
12.
Prathipati, Pavan Kumar, Subhra Mandal, & Christopher J. Destache. (2018). Development and validation of LC–MS/MS method for quantification of bictegravir in human plasma and its application to an intracellular uptake study. Biomedical Chromatography. 33(2). e4379–e4379. 22 indexed citations
13.
Prathipati, Pavan Kumar, Subhra Mandal, & Christopher J. Destache. (2018). LC–MS/MS method for the simultaneous determination of tenofovir, emtricitabine, elvitegravir and rilpivirine in dried blood spots. Biomedical Chromatography. 32(9). e4270–e4270. 6 indexed citations
14.
Pattnaik, Aryamav, Nicholas Y. Palermo, Bikash R. Sahoo, et al.. (2017). Discovery of a non-nucleoside RNA polymerase inhibitor for blocking Zika virus replication through in silico screening. Antiviral Research. 151. 78–86. 48 indexed citations
15.
Prathipati, Pavan Kumar, et al.. (2017). Pharmacokinetic and Tissue Distribution Profile of Long Acting Tenofovir Alafenamide and Elvitegravir Loaded Nanoparticles in Humanized Mice Model. Pharmaceutical Research. 34(12). 2749–2755. 27 indexed citations
16.
Mandal, Subhra, et al.. (2017). Nucleotide Reverse Transcriptase Inhibitors: A Thorough Review, Present Status and Future Perspective as HIV Therapeutics. Current HIV Research. 15(6). 411–421. 78 indexed citations
17.
Mandal, Subhra, et al.. (2017). Cellulose Acetate Phthalate and Antiretroviral Nanoparticle Fabrications for HIV Pre-Exposure Prophylaxis. Polymers. 9(9). 423–423. 16 indexed citations
18.
Mandal, Subhra, Pavan Kumar Prathipati, Guobin Kang, et al.. (2016). Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission. AIDS. 31(4). 469–476. 40 indexed citations
19.
Prathipati, Pavan Kumar, Subhra Mandal, & Christopher J. Destache. (2016). Simultaneous quantification of tenofovir, emtricitabine, rilpivirine, elvitegravir and dolutegravir in mouse biological matrices by LC–MS/MS and its application to a pharmacokinetic study. Journal of Pharmaceutical and Biomedical Analysis. 129. 473–481. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Timothy McCormick Breakdown of academic impact, for papers by Guenter Kraus Breakdown of academic impact, for papers by Inês Bártolo Breakdown of academic impact, for papers by Yeojin Park Breakdown of academic impact, for papers by Jeong-Joong Yoon Breakdown of academic impact, for papers by Murty N. Arimilli Breakdown of academic impact, for papers by Carrie A. Rutkowski Breakdown of academic impact, for papers by Yi-Fei Gong Breakdown of academic impact, for papers by Sophie Lachau‐Durand Breakdown of academic impact, for papers by Katie Amssoms
Rankless by CCL
2026